Subdermal Contraceptive Implants Market Growth and Forecast 2034
Global Subdermal Contraceptive Implants Market Size- By Product, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Sep-2025 | Report ID: HLCA25270 | Pages: 1 - 269 | Formats*: |
| Category : Healthcare | |||
Global Subdermal Contraceptive Implants Market Introduction and Overview
According to SPER Market Research, the Global Subdermal Contraceptive Implants Market is estimated to reach USD 2.39 billion by 2034 with a CAGR of 7.89%.
The report includes an in-depth analysis of the Global Subdermal Contraceptive Implants Market, including market size and trends, product mix, Applications, and supplier analysis. The Global Subdermal Contraceptive Implants market was valued at USD 1.12 billion in 2024 and is projected to increase at a compound annual growth rate (CAGR) of 7.89% between 2025 and 2034. The market growth is driven by rising demand for reliable contraceptives, increasing unintended pregnancies, and growing awareness of sexual health and family planning. The high number of unintended pregnancies boosts demand for subdermal contraceptive implants as a long-term solution. According to UNFPA data from March 2022, an estimated 121 million unintended pregnancies underscore the need for effective and accessible family planning methods, fueling market expansion.
By Product Insights
The etonogestrel implant segment leads the market due to increasing unintended pregnancies and unsafe abortions. Many women seek to delay or avoid pregnancy, making long-term, effective contraceptives like etonogestrel implants popular. These implants offer reliable pregnancy prevention over several years with a low failure rate and are more cost-effective for long-term use compared to other contraceptives, driving strong market growth.
The levonorgestrel implant segment is also expected to grow significantly, supported by ongoing family planning needs and efforts to reduce unintended pregnancies and unsafe abortions. Levonorgestrel implants provide continuous hormone release for long-term pregnancy prevention and are favored for their reliability and convenience, making them a preferred option for women looking to delay pregnancy, thus expanding the market.
By Distribution Channel Insights
Hospitals lead the market because they offer a comprehensive range of services, including tests, consultations, and procedures, which attract patients and drive growth. They are equipped with advanced medical technologies, ensuring high-quality care. Hospitals provide integrated healthcare services such as examinations, counseling, and subdermal contraceptive implant procedures under professional supervision. This complete and trusted care environment makes hospitals the preferred choice for many, supporting strong expansion of this segment.
Gynecology clinics are projected to grow the fastest due to the increasing demand for specialized contraceptive services and the rising number of abortions and healthcare consultations. These clinics offer expert gynecological exams, contraceptive implant placements, abortion procedures, and follow-up care.
Regional Insights
North America dominates the subdermal contraceptive implants market due to rising unintended pregnancies, a growing number of gynecology clinics, and supportive government initiatives. For example, the Canadian government is working to reduce unintended pregnancies by increasing sexual health awareness and plans to provide contraceptive medications and devices, including implants, free of cost. These efforts are expected to significantly boost market growth in the region.
Market Competitive Landscape
Leading companies focus on strategic activities like developing innovative products, collaborating with academic institutions and other industries, and forming partnerships to strengthen their market position. Some key players are- Bayer AG, Baxter, BD, Gerresheimer AG, Lilly, Merck & Co., Inc., Novartis AG, Pfizer, Inc., SCHOTT, and Shanghai Dahua Pharmaceutical Co., Ltd.
Recent Developments:
In February 2024, Bayer AG partnered with DARÉ BIOSCIENCE to develop an innovative hormone-free monthly contraceptive. Dr. Marianne de Backer, Executive Committee member at Bayer, highlighted the collaboration as a strategic move aligned with their vision to provide women with differentiated contraceptive options, reinforcing Bayer’s leadership in women’s health.
In December 2023, the Odisha state government in India introduced two new contraceptive options as part of the Family Planning Roadmap-2030. Four districts in Odisha were selected among 40 districts across 10 states to pilot the use of subdermal implants (single flexible rod) and the subcutaneous injectable contraceptive Antara, aiming to enhance family planning services and expand contraceptive access for women.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Distribution Channel |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Bayer AG, Baxter, BD, Gerresheimer AG, Lilly, Merck & Co., Inc., Novartis AG, Pfizer, Inc., SCHOTT, and Shanghai Dahua Pharmaceutical Co., Ltd. |
Key Topics Covered in the Report
- Global Subdermal Contraceptive Implants Market Size (FY’2021-FY’2034)
- Overview of Global Subdermal Contraceptive Implants Market
- Segmentation of Global Subdermal Contraceptive Implants Market By Product (Etonogestrel Implant, Levonorgestrel Implant)
- Segmentation of Global Subdermal Contraceptive Implants Market By Distribution Channel (Hospital, Gynecology Clinics, Community Health Care Centers, Others)
- Statistical Snap of Global Subdermal Contraceptive Implants Market
- Expansion Analysis of Global Subdermal Contraceptive Implants Market
- Problems and Obstacles in Global Subdermal Contraceptive Implants Market
- Competitive Landscape in the Global Subdermal Contraceptive Implants Market
- Details on Current Investment in Global Subdermal Contraceptive Implants Market
- Competitive Analysis of Global Subdermal Contraceptive Implants Market
- Prominent Players in the Global Subdermal Contraceptive Implants Market
- SWOT Analysis of Global Subdermal Contraceptive Implants Market
- Global Subdermal Contraceptive Implants Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Subdermal Contraceptive Implants Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Subdermal Contraceptive Implants Market
7.Global Subdermal Contraceptive Implants Market, By Product (USD Million) 2021-2034
7.1.Etonogestrel Implant7.2.Levonorgestrel Implant
8.Global Subdermal Contraceptive Implants Market, By Distribution Channel (USD Million) 2021-2034
8.1.Hospital8.2.Gynecology Clinics8.3.Community Health Care Centers8.4.Others
9.Global Subdermal Contraceptive Implants Market, (USD Million) 2021-2034
9.1.Global Subdermal Contraceptive Implants Market Size and Market Share
10.Global Subdermal Contraceptive Implants Market, By Region, (USD Million) 2021-2034
10.1.Asia-Pacific
10.1.1.Australia10.1.2.China10.1.3.India10.1.4.Japan10.1.5.South Korea10.1.6.Rest of Asia-Pacific
10.2.Europe
10.2.1.France10.2.2.Germany10.2.3.Italy10.2.4.Spain10.2.5.United Kingdom10.2.6.Rest of Europe
10.3.Middle East and Africa
10.3.1.Kingdom of Saudi Arabia10.3.2.United Arab Emirates10.3.3.Qatar10.3.4.South Africa10.3.5.Egypt10.3.6.Morocco10.3.7.Nigeria10.3.8.Rest of Middle-East and Africa
10.4.North America
10.4.1.Canada10.4.2.Mexico10.4.3.United States
10.5.Latin America
10.5.1.Argentina10.5.2.Brazil10.5.3.Rest of Latin America
11.Company Profile
11.1. Bayer AG
11.1.1.Company details11.1.2.Financial outlook11.1.3.Product summary11.1.4.Recent developments
11.2. Baxter
11.2.1.Company details11.2.2.Financial outlook11.2.3.Product summary11.2.4.Recent developments
11.3. BD
11.3.1.Company details11.3.2.Financial outlook11.3.3.Product summary11.3.4.Recent developments
11.4. Gerresheimer AG
11.4.1.Company details11.4.2.Financial outlook11.4.3.Product summary11.4.4.Recent developments
11.5. Lilly
11.5.1.Company details11.5.2.Financial outlook11.5.3.Product summary11.5.4.Recent developments
11.6. Merck & Co., Inc.
11.6.1.Company details11.6.2.Financial outlook11.6.3.Product summary11.6.4.Recent developments
11.7. Novartis AG
11.7.1.Company details11.7.2.Financial outlook11.7.3.Product summary11.7.4.Recent developments
11.8. Pfizer, Inc.
11.8.1.Company details11.8.2.Financial outlook11.8.3.Product summary11.8.4.Recent developments
11.9. SCHOTT
11.9.1.Company details11.9.2.Financial outlook11.9.3.Product summary11.9.4.Recent developments
11.10. Shanghai Dahua Pharmaceutical Co., Ltd.
11.10.1.Company details11.10.2.Financial outlook11.10.3.Product summary11.10.4.Recent developments
11.11.Others
12.Conclusion
13.List of Abbreviations
14.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Subdermal Contraceptive Implants Market is projected to reach USD 2.39 billion by 2034, growing at a CAGR of 7.89% during the forecast period.
Subdermal Contraceptive Implants Market size from 2025. The Market is expected to reach USD 2.39 billion by 2034, at a CAGR of 7.89% during the forecast period.
Subdermal Contraceptive Implants Market CAGR of 7.89% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Subdermal Contraceptive Implants Market size is USD 2.39 billion from 2025 to 2034.
Subdermal Contraceptive Implants Market covered By Product, By Distribution Channel
The North America is anticipated to have the highest Market share in the Subdermal Contraceptive Implants Market.
Bayer AG, Baxter, BD, Gerresheimer AG, Lilly, Merck & Co., Inc., Novartis AG, Pfizer, Inc., SCHOTT, and Shanghai Dahua Pharmaceutical Co., Ltd.
The report includes an in-depth analysis of the Global Subdermal Contraceptive Implants Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
